These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22118942)

  • 1. Alterations in the histaminergic system in the substantia nigra and striatum of Parkinson's patients: a postmortem study.
    Shan L; Bossers K; Luchetti S; Balesar R; Lethbridge N; Chazot PL; Bao AM; Swaab DF
    Neurobiol Aging; 2012 Jul; 33(7):1488.e1-13. PubMed ID: 22118942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease.
    Anichtchik OV; Peitsaro N; Rinne JO; Kalimo H; Panula P
    Neurobiol Dis; 2001 Aug; 8(4):707-16. PubMed ID: 11493035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An altered histaminergic innervation of the substantia nigra in Parkinson's disease.
    Anichtchik OV; Rinne JO; Kalimo H; Panula P
    Exp Neurol; 2000 May; 163(1):20-30. PubMed ID: 10785440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in the histaminergic system in Alzheimer's disease: a postmortem study.
    Shan L; Bossers K; Unmehopa U; Bao AM; Swaab DF
    Neurobiol Aging; 2012 Nov; 33(11):2585-98. PubMed ID: 22284987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of histamine H3 receptors in the brain of 6-hydroxydopamine-lesioned rats.
    Anichtchik OV; Huotari M; Peitsaro N; Haycock JW; Männistö PT; Panula P
    Eur J Neurosci; 2000 Nov; 12(11):3823-32. PubMed ID: 11069577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia.
    Allen AM; MacGregor DP; Chai SY; Donnan GA; Kaczmarczyk S; Richardson K; Kalnins R; Ireton J; Mendelsohn FA
    Ann Neurol; 1992 Sep; 32(3):339-44. PubMed ID: 1416803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.
    Sedaghat K; Finkelstein DI; Gundlach AL
    Brain Res; 2009 May; 1271():83-94. PubMed ID: 19328193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.
    Mogi M; Kondo T; Mizuno Y; Nagatsu T
    Neurosci Lett; 2007 Feb; 414(1):94-7. PubMed ID: 17196747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between levels of pigment epithelium-derived factor and vascular endothelial growth factor in the striatum of patients with Parkinson's disease.
    Yasuda T; Fukuda-Tani M; Nihira T; Wada K; Hattori N; Mizuno Y; Mochizuki H
    Exp Neurol; 2007 Aug; 206(2):308-17. PubMed ID: 17604022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.
    Péran P; Cherubini A; Assogna F; Piras F; Quattrocchi C; Peppe A; Celsis P; Rascol O; Démonet JF; Stefani A; Pierantozzi M; Pontieri FE; Caltagirone C; Spalletta G; Sabatini U
    Brain; 2010 Nov; 133(11):3423-33. PubMed ID: 20736190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.
    Jin L; Wang J; Zhao L; Jin H; Fei G; Zhang Y; Zeng M; Zhong C
    Brain; 2011 Jan; 134(Pt 1):50-8. PubMed ID: 21109502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra.
    Howells DW; Porritt MJ; Wong JY; Batchelor PE; Kalnins R; Hughes AJ; Donnan GA
    Exp Neurol; 2000 Nov; 166(1):127-35. PubMed ID: 11031089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased brain histamine H3 receptor expression during hibernation in golden-mantled ground squirrels.
    Sallmen T; Lozada AF; Anichtchik OV; Beckman AL; Panula P
    BMC Neurosci; 2003 Sep; 4():24. PubMed ID: 14505495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models.
    Martínez-Mir MI; Pollard H; Moreau J; Traiffort E; Ruat M; Schwartz JC; Palacios JM
    Synapse; 1993 Nov; 15(3):209-20. PubMed ID: 7904088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.
    He N; Ling H; Ding B; Huang J; Zhang Y; Zhang Z; Liu C; Chen K; Yan F
    Hum Brain Mapp; 2015 Nov; 36(11):4407-20. PubMed ID: 26249218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal histamine production remains unaltered in Parkinson's disease despite the accumulation of Lewy bodies and Lewy neurites in the tuberomamillary nucleus.
    Shan L; Liu CQ; Balesar R; Hofman MA; Bao AM; Swaab DF
    Neurobiol Aging; 2012 Jul; 33(7):1343-4. PubMed ID: 21371786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease.
    Geng DY; Li YX; Zee CS
    Neurosurgery; 2006 Feb; 58(2):256-62; discussion 256-62. PubMed ID: 16462479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.
    Murray AM; Weihmueller FB; Marshall JF; Hurtig HI; Gottleib GL; Joyce JN
    Ann Neurol; 1995 Mar; 37(3):300-12. PubMed ID: 7695230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.